VS BioClinical
0757.634.336 · rovalta.com · 25/09/2026
VS BioClinical
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOVS BioClinical is a Private limited company incorporated in 2020. Its registered office is in Saint-Nicolas.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0757.634.336
- Incorporation
- 29/10/2020
- Legal form
- Private limited company
- Registered office
- Rue Voie des Vaux 34 box 11
4420 Saint-Nicolas · WallonieSee on map - Contributed capital
- 2 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 237,7 k € | -8.3% | 259,1 k € | +0.5% | 258 k € | +3.8% | 248,5 k € | +42.6% | 174,2 k € |
| EBITDA | 237,3 k € | -8.2% | 258,4 k € | +0.2% | 258 k € | +3.8% | 248,5 k € | +42.8% | 174 k € |
| Operating result | 228,6 k € | -8.4% | 249,5 k € | -0.2% | 250,1 k € | +3.4% | 241,9 k € | +39.2% | 173,8 k € |
| Net result | 178,1 k € | -6.5% | 190,5 k € | +10.6% | 172,3 k € | +2.8% | 167,6 k € | +37.4% | 121,9 k € |
| Balance sheet | |||||||||
| Equity | 463,8 k € | 0.0% | 463,8 k € | 0.0% | 463,8 k € | +59.1% | 291,5 k € | +135% | 123,9 k € |
| Total assets | 644,4 k € | -6.9% | 692,1 k € | +37.1% | 505 k € | +49.6% | 337,5 k € | +88.0% | 179,6 k € |
| Cash | 79,1 k € | -56.4% | 181,7 k € | -19.2% | 224,9 k € | -13.8% | 260,9 k € | +64.2% | 158,9 k € |
| Debts | 180,4 k € | -20.9% | 228,1 k € | +457% | 41 k € | -10.6% | 45,8 k € | -17.6% | 55,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Rue Voie des Vaux 34 4420 Saint-Nicolas| Company | CBE no. |
|---|---|
| 0767.765.193 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/12/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 13 months |
| Filing date | 08/04/2026 | 16/06/2025 | 17/06/2024 | 19/06/2023 | 27/06/2022 |
| General meeting | 27/03/2026 | 15/06/2025 | 15/06/2024 | 15/06/2023 | 15/06/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 5 filingsValuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025178,1 k €↓
- 2024Annual accounts 2024190,5 k €↑
- 2023Annual accounts 2023172,3 k €↑
- 2022Annual accounts 2022167,6 k €↑
- 2021Annual accounts 2021121,9 k €
- 29/10/2020IncorporationPrivate limited company